moxonidine has been researched along with reserpine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Koch, HF; Webster, J | 1 |
| Penner, SB; Smyth, DD | 1 |
| Robles, NR | 1 |
| Hashimoto, M; Ono, H; Tanabe, M | 1 |
1 review(s) available for moxonidine and reserpine
| Article | Year |
|---|---|
Aspects of tolerability of centrally acting antihypertensive drugs.
Topics: Antihypertensive Agents; Clonidine; Humans; Imidazoles; Methyldopa; Reserpine; Substance Withdrawal Syndrome | 1996 |
4 other study(ies) available for moxonidine and reserpine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antihypertensive Agents; Brain; Idazoxan; Imidazoles; Imidazoline Receptors; Injections; Injections, Intravenous; Injections, Intraventricular; Kidney; Male; Natriuresis; Peripheral Nervous System; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Drug; Reserpine; Sodium; Sympathectomy | 1998 |
[New central agents in the treatment of arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clonidine; Diabetes Complications; Humans; Hypertension; Imidazoles; Nifedipine; Oxazoles; Renin-Angiotensin System; Reserpine; Rilmenidine; Risk Factors; Sympathetic Nervous System; Vasodilator Agents | 1999 |
Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzazepines; Benzofurans; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Idazoxan; Imidazoles; Imidazoline Receptors; Injections, Intraperitoneal; Ligands; Male; Mice; Muscle Rigidity; Muscle, Skeletal; Parkinsonian Disorders; Reserpine; Time Factors; Yohimbine | 2008 |